VANGUARD GROUP INC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,424,912
-62.4%
1,630,688
+1.5%
0.00%
Q2 2023$17,080,114
+81.1%
1,606,784
+41.9%
0.00%
Q1 2023$9,429,452
-36.2%
1,131,987
-29.3%
0.00%
Q4 2022$14,786,876
-43.8%
1,602,045
-21.8%
0.00%
-100.0%
Q3 2022$26,295,000
-0.2%
2,047,904
+2.7%
0.00%0.0%
Q2 2022$26,354,000
-35.4%
1,995,033
+2.9%
0.00%0.0%
Q1 2022$40,824,000
-11.0%
1,939,390
+1.4%
0.00%0.0%
Q4 2021$45,873,000
-2.4%
1,912,182
+3.5%
0.00%0.0%
Q3 2021$47,003,000
-19.7%
1,847,615
+6.3%
0.00%0.0%
Q2 2021$58,527,000
-9.3%
1,738,802
+4.7%
0.00%
-50.0%
Q1 2021$64,514,000
-35.1%
1,661,011
+3.4%
0.00%
-33.3%
Q4 2020$99,475,000
+127.4%
1,606,268
+23.0%
0.00%
+200.0%
Q3 2020$43,737,000
+43.6%
1,305,960
+2.2%
0.00%0.0%
Q2 2020$30,462,000
+67.1%
1,278,341
+60.6%
0.00%0.0%
Q1 2020$18,229,000
-16.7%
795,990
+3.0%
0.00%0.0%
Q4 2019$21,886,000
+51.2%
772,804
+14.7%
0.00%0.0%
Q3 2019$14,476,000
+396.3%
673,584
+573.6%
0.00%
Q2 2019$2,917,000100,0000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$9,991,0002.07%
RTW INVESTMENTS, LP 3,644,248$122,665,0001.85%
Cormorant Asset Management, LP 1,278,276$43,027,0001.46%
Redmile Group, LLC 2,458,558$82,755,0001.22%
SPHERA FUNDS MANAGEMENT LTD. 233,135$7,847,0000.53%
Birchview Capital, LP 15,000$505,0000.30%
Perceptive Advisors 1,343,956$45,238,0000.29%
GILDER GAGNON HOWE & CO LLC 1,245,956$41,939,0000.21%
Artal Group S.A. 250,000$8,415,0000.17%
Casdin Capital, LLC 120,000$4,039,0000.10%
View complete list of STOKE THERAPEUTICS INC shareholders